Zero Revenue, 46,000% Surge: The Absurd Anatomy of the Regencell Bioscience Stock Fraud Investigation

How does a company with zero revenue and a vacant Chief Medical Officer hit a $30 billion valuation? It doesn’t—not legally. This is the story of Regencell Bioscience, a scheme so blatant it triggered a DOJ criminal probe. Today, we’re dissecting exactly how they built this house of cards, and how it all came crashing down.

Read the full post: https://doomscrollnews.com/rgc-pump-and-dump-investigation/

Doomscroll Dispatch
Doomscroll Dispatch
Zero Revenue, 46,000% Surge: The Absurd Anatomy of the Regencell Bioscience Stock Fraud Investigation
Loading
/

Comments

Leave a Reply